NRIX

8.81

8.23% -0.79

Dopo l'orario di chiusura: 8.81

Nurix Therapeutics Inc (NRIX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$9.60

Aprire:

$9.35

Volume 24 ore:

1.45M

Relative Volume:

1.69

Capitalizzazione di mercato:

$671.64M

Reddito:

$54.55M

Utile/perdita netta:

$-193.57M

Rapporto P/E:

-3.0484

EPS:

-2.89

Flusso di cassa netto:

$-181.86M

1 W Prestazione:

-16.18%

1M Prestazione:

-35.17%

6M Prestazione:

-59.70%

1 anno Prestazione:

-43.85%

Intervallo 1D:

$8.18

$9.9303

Intervallo di 1 settimana:

$8.18

$10.52

Portata 52W:

$8.18

$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Nome

Nurix Therapeutics Inc

Settore

Healthcare (1159)

Industria

Biotechnology (667)

Telefono

(415) 660-5320

Indirizzo

1700 OWENS STREET, SUITE 205, SAN FRANCISCO

Dipendente

286

Cinguettio

Prossima data di guadagno

2025-04-09

Ultimi documenti SEC

NRIX's Discussions on Twitter

Confronta NRIX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NRIX Nurix Therapeutics Inc	8.81	671.64M	54.55M	-193.57M	-181.86M	-2.89
VRTX Vertex Pharmaceuticals Inc	475.49	122.24B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	546.39	59.73B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	546.22	33.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	226.28	29.29B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	208.31	22.44B	3.81B	-644.79M	-669.77M	-6.24

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-17	Iniziato	Leerink Partners	Market Perform
2024-12-10	Iniziato	BTIG Research	Buy
2024-12-06	Iniziato	BMO Capital Markets	Outperform
2024-10-24	Iniziato	UBS	Buy
2024-10-11	Iniziato	Jefferies	Buy
2024-09-06	Ripresa	Robert W. Baird	Outperform
2024-07-31	Iniziato	Truist	Buy
2023-06-26	Ripresa	Oppenheimer	Outperform
2023-03-09	Iniziato	Barclays	Overweight
2023-02-28	Iniziato	Oppenheimer	Outperform
2022-10-11	Iniziato	Morgan Stanley	Equal-Weight
2022-05-31	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-02-10	Iniziato	Wells Fargo	Equal Weight
2021-12-29	Iniziato	H.C. Wainwright	Buy
2021-10-14	Iniziato	SVB Leerink	Outperform
2021-06-04	Ripresa	Robert W. Baird	Outperform
2021-04-30	Ripresa	Piper Sandler	Overweight
2021-04-30	Iniziato	RBC Capital Mkts	Outperform
2021-04-14	Iniziato	Berenberg	Buy
2020-11-19	Iniziato	Robert W. Baird	Outperform
2020-08-18	Iniziato	JP Morgan	Overweight
2020-08-18	Iniziato	Needham	Buy
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-18	Iniziato	Stifel	Buy

Mostra tutto

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

10:10 AM

UBS Adjusts Price Target on Nurix Therapeutics to $30 From $35, Keeps Buy Rating - MarketScreener

10:10 AM

07:24 AM

Nurix Therapeutics (NRIX) Sees Price Target Reduction Amid Ongoi - GuruFocus

07:24 AM

Apr 09, 2025

Wellington Management Group LLP Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Apr 09, 2025

Nurix Therapeutics (NASDAQ:NRIX) Sets New 1-Year LowTime to Sell? - MarketBeat

Apr 09, 2025

Grains Bottom and Why - The Globe and Mail

Apr 09, 2025

Nurix Therapeutics price target lowered to $25 from $32 at Wells Fargo - TipRanks

Apr 09, 2025

Nurix Therapeutics price target lowered to $35 from $36 at Stifel - TipRanks

Apr 09, 2025

Polymer Capital Management HK LTD Acquires Shares of 50,098 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Apr 09, 2025

Apr 08, 2025

Nurix Therapeutics Q1 2025 Financial Highlights - TipRanks

Apr 08, 2025

Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update | NRIX Stock News - GuruFocus

Apr 08, 2025